Results 131 to 140 of about 5,352 (210)

Risk factors of hepatotoxicity with ribociclib in hormone receptor-positive breast cancer. [PDF]

J Chin Med Assoc
Lin WC, Chang YL, Wang SF, Hsu CC, Chou CY, Tseng LM, Chao TC.   +6 more
europepmc   +1 more source

The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV. [PDF]

Infect Dis Ther
Zheng Y, Wire M, Omange RW, deVries CR, Zhang L, Chen B, Huang SSY, Cruz K, Hassman H, Osiyemi O, Rondon JC, Lim D, West S, Wen A, Wallin JJ, SenGupta D, Cai Y.   +16 more
europepmc   +1 more source

Voriconazole therapeutic drug monitoring and safety in HIV-infected patients with invasive fungal disease. [PDF]

Front Pharmacol
Hu L, Su Y, Hou J, Li Y, He C.
europepmc   +1 more source

Gender Differences in Statin Discontinuation and Adherence Among Privately Insured People with HIV in the USA. [PDF]

J Gen Intern Med
Davy-Mendez T, Kinlaw AC, Tungate Lopez S, Okeke NL, Floris-Moore M, Eron JJ, Avery CL, Berry SA, Crane HM, Golin CE, Napravnik S, Simpson RJ.   +11 more
europepmc   +1 more source

Dual Long-Acting Cabotegravir/Rilpivirine Plus Lenacapavir in Integrase Strand Transfer Inhibitor Resistance: A Case Report and Review of the Literature. [PDF]

Open Forum Infect Dis
Seo L, Reilly-Evans B, Garland J.
europepmc   +1 more source

Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium. [PDF]

Front Pharmacol
Lopez Delhoulle V, Destordeur LC, Maes N, Fombellida K, El Moussaoui M, Darcis G.   +5 more
europepmc   +1 more source

Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study. [PDF]

Infect Dis Ther
Mounzer K, Osterman MD, Brunet L, Hsu RK, Mills AM, Pierone G, Sension MG, Fusco JS, Fleming SP, Prajapati G, Fusco GP.   +10 more
europepmc   +1 more source

Hope for kidney transplantation in candidates with human immunodeficiency virus. [PDF]

World J Transplant
Belal AA, Bourricaudy RA, Saba Z, Ali S, Haddad I, Santos AH.   +5 more
europepmc   +1 more source

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort. [PDF]

Infect Dis Rep
Ceccarelli M, Venanzi Rullo E, Marino A, De Vito A, Micali C, Spampinato S, Russotto Y, Albanese A, Frasca MC, Sofia SA, Pellicanò GF, Celesia BM, Maggi P, Madeddu G, Nunnari G.   +14 more
europepmc   +1 more source

Real-world pharmacovigilance of drug-related bone metabolism disorders: integrating FAERS and VigiAccess with a Bradford Hill-based causal plausibility assessment. [PDF]

Front Pharmacol
Liu P, Zhao K, Zhang H, Liu MQ, Li J, Sun Y.   +5 more
europepmc   +1 more source